Growth Metrics

Palisade Bio (PALI) EPS (Basic) Growth (3y) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) Growth (3y) (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - 139.68%
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn 25.99%
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - 41.58%
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn 14.28%
7 Evaxion A 62.56 Bn 62.54 Bn - 58.35%
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -2.92%
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn 45.92%
10 Palisade Bio 439.25 Mn 309.68 Mn - 81.68%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 81.68%
Dec 31, 2025 -16.72%
Sep 30, 2025 54.74%
Jun 30, 2025 53.50%
Mar 31, 2025 66.90%
Dec 31, 2024 82.96%
Sep 30, 2024 -95.95%
Jun 30, 2024 2.57%
Mar 31, 2024 -79.77%
Dec 31, 2023 -35.07%
Sep 30, 2023 -123.62%
Jun 30, 2023 -127.89%
Mar 31, 2023 -13.37%
Dec 31, 2022 23.20%
Sep 30, 2022 -90.83%
Jun 30, 2022 -58.47%
Mar 31, 2022 -55.90%
Dec 31, 2021 -357.11%
Sep 30, 2021 29.55%
Jun 30, 2021 -62.93%
Mar 31, 2021 -78.03%
Dec 31, 2020 -97.04%
Sep 30, 2020 -304.12%
Jun 30, 2020 -19.77%
Mar 31, 2020 -101.70%
Dec 31, 2019 55.42%
Sep 30, 2019 0.00%
Jun 30, 2019 -45.58%
Mar 31, 2019 -54.35%
Dec 31, 2018 -207.94%
Sep 30, 2018 -242.47%
Jun 30, 2018 -140.05%
Mar 31, 2018 -32.64%
Dec 31, 2017 -49.38%
Sep 30, 2017 41.52%
Jun 30, 2017 -69.56%
Mar 31, 2017 -113.37%
Dec 31, 2016 -142.44%
Sep 30, 2016 -87.16%
Jun 30, 2016 -73.49%
Mar 31, 2016 -164.95%
Dec 31, 2015 -7.72%
Sep 30, 2015 -14.47%
Jun 30, 2015 -14.47%
Mar 31, 2015 -6.27%
Dec 31, 2014 -6.27%
Sep 30, 2014 10.61%
Jun 30, 2014 0.00%
Mar 31, 2014 0.00%
Dec 31, 2013 7.17%
Sep 30, 2013 0.00%
Jun 30, 2013 9.14%